Studies have now examined BPC-157 in models of tendon injury, traumatic brain injury, peripheral nerve damage, cardiovascular stress, liver toxicity, kidney damage, and even mood regulation a scope that is extraordinary for a single research compound
Last quarter alone, its two leading GLP-1 drugs, Mounjaro and Zepbound, generated a combined $5.4 billion in revenue
5 Its currently available through private providers, with NHS access expected later in 2026
Think of your brain as a city: Most supplements patch potholes on existing roads
Remove the needle from the vial carefully and dont bend it
And it matters because the psychiatric applications of GLP-1 analogs, including emerging evidence for efficacy in addiction, depression, and other conditions, remain largely unexplored through the lens of sex